We first assessed migration of prostate neuroendocrine tumor cells derived form CR2-TAg mouse tumors (PNEC cells, [23]), in 3D matrigel co-cultures with wt (CTSD+/+) or cathepsin D-deficient (CTSD−/−) fibroblasts. The gene discussed is CTSD; the disease is urogenital neoplasm.